Evidence map›Paper›PMID 31160613›Full record

ArticleScientific reports2019

In-feed bacitracin methylene disalicylate modulates the turkey microbiota and metabolome in a dose-dependent manner.

Timothy A Johnson, Matthew J Sylte, Torey Looft

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
6.3field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 68 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Intestinal Damages by F18Antioxidants (Basel, Switzerland) · 2023
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. International journal of systematic and evolutionary microbiology · 2022
    Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Complete Genome Sequence and Annotation forMicrobiology resource announcements · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Timothy A JohnsonNational Animal Disease Center, Agricultural Research Service, United States Department of Agriculture, Ames, IA, 50010, USA.ORCID https://orcid.org/0000-0001-8204-547X
Matthew J SylteNational Animal Disease Center, Agricultural Research Service, United States Department of Agriculture, Ames, IA, 50010, USA.ORCID https://orcid.org/0000-0001-6921-948X
Torey LooftNational Animal Disease Center, Agricultural Research Service, United States Department of Agriculture, Ames, IA, 50010, USA. torey.looft@ars.usda.gov.ORCID http://orcid.org/0000-0001-8066-6715
Agricultural Research Service · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Beginning in 2017, the subtherapeutic use of most antibiotic compounds for growth promotion in food producing animals in the US was prohibited, highlighting the need to discover alternative growth promotants. Identifying the mechanism of action of growth promoting antibiotics may aid in the discovery of antibiotic alternatives. We describe the effects of feeding a subtherapeutic (50 g/ton of feed) and therapeutic (200 g/ton) concentration of bacitracin methylene disalicylate (BMD) to commercial turkeys for 14 weeks, and its effect on turkey intestinal microbial communities and cecal metabolomes. Both BMD concentrations had an immediate and lasting impact on the microbiota structure, and reduced bacterial richness through the end of the study (12 weeks). Metabolomic analysis identified 712 biochemicals, and 69% of metabolites were differentially present in BMD treated turkeys for at least one time point (q < 0.1). Amino acids, carbohydrates, nucleotides, peptides, and lipids were decreased in the turkey ceca early after BMD administration. Long-term metabolome alterations continued even after withdrawal of BMD. The microbial composition, determined by 16S rRNA gene sequencing, was predictive of the metabolome, indicating a connection between the microbiome and metabolome. In-feed BMD may cause bacterial metabolic shifts, leading to beneficial traits that can be targeted to improve animal health and production.

Indexed as

Amino AcidsAnimal FeedAnimalsBacitracinBacteriaBiodiversityCecumMaleMetabolomeMicrobiotaSalicylatesTime FactorsTurkeysAmino AcidsBacitracinbacitracin methylenedisalicylic acidSalicylates

Identifiers

PMID31160613
PMCPMC6547706
OpenAlexW2948680729

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.